High-risk human papillomavirus seems not involved in DES-related and of limited importance in nonDES related clear-cell carcinoma of the cervix

Gynecologic Oncology

Volumn 122, Issue 2, 2011, Pages 297-302

  Kocken, Mariëlle ^a,b   Baalbergen, Astrid ^c   Snijders, Peter J F ^b   Bulten, Johan ^d   Quint, Wim G V ^e   Smedts, Frank ^a   Meijer, Chris J L M ^b   Helmerhorst, Theo J M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c REINIER DE GRAAF HOSPITAL   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e DDL DIAGNOSTIC LABORATORY   (Netherlands)

Author keywords

Cervix; Clear cell adenocarcinoma; Diethylstilbestrol; Human papillomavirus; p16INK4a

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; DIETHYLSTILBESTROL; PROTEIN P53;

ADULT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EXPOSURE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFECTION RISK; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CLEAR CELL ADENOCARCINOMA; WART VIRUS;

ADENOCARCINOMA, CLEAR CELL; ADOLESCENT; ADULT; DIETHYLSTILBESTROL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM PROTEINS; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RISK; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

EID: 79960460808     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.05.002     Document Type: Article

References (37)

1. O. Reich, K. Tamussino, M. Lahousen, H. Pickel, J. Haas, and R. Winter Clear cell carcinoma of the uterine cervix: pathology and prognosis in surgically treated stage IB-IIB disease in women not exposed in utero to diethylstilbestrol Gynecol Oncol 76 2000 331 335 (Pubitemid 30131503)
2. E.C. Pirog, B. Kleter, S. Olgac, P. Bobkiewicz, J. Lindeman, and W.G. Quint Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma Am J Pathol 157 2000 1055 1062
3. A.L. Herbst Behavior of estrogen-associated female genital tract cancer and its relation to neoplasia following intrauterine exposure to diethylstilbestrol (DES) Gynecol Oncol 76 2000 147 156 (Pubitemid 30067188)
4. A. Hanselaar, M. van Loosbroek, O. Schuurbiers, T. Helmerhorst, J. Bulten, and J. Bernhelm Clear cell adenocarcinoma of the vagina and cervix. An update of the central Netherlands registry showing twin age incidence peaks Cancer 79 1997 2229 2236 (Pubitemid 27227389)
5. O.W. Smith, G.V.S. Smith, and D. Hurwitz Increased excretion of pregnanediol in pregnancy from diethylstilbestrol with special reference to the prevention of late pregnancy accidents Med Rec Ann 40 1946 1669 1671
6. A.L. Herbst, H. Ulfelder, and D.C. Poskanzer Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women N Engl J Med 284 1971 878 881
7. S. Melnick, P. Cole, D. Anderson, and A. Herbst Rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix. An update N Engl J Med 316 1987 514 516 (Pubitemid 17035554)
8. R. Troisi, E.E. Hatch, L. Titus-Ernstoff, M. Hyer, J.R. Palmer, and S.J. Robboy Cancer risk in women prenatally exposed to diethylstilbestrol Int J Cancer 121 2007 356 360 (Pubitemid 46917705)
9. M.B. Thomas, J.D. Wright, A.L. Leiser, D.S. Chi, D.G. Mutch, and K.C. Podratz Clear cell carcinoma of the cervix: a multi-institutional review in the post-DES era Gynecol Oncol 109 2008 335 339
10. S.E. Waggoner, R. Mittendorf, N. Biney, D. Anderson, and A.L. Herbst Influence of in utero diethylstilbestrol exposure on the prognosis and biologic behavior of vaginal clear-cell adenocarcinoma Gynecol Oncol 55 1994 238 244 (Pubitemid 24366633)
11. J.M. Walboomers, M.V. Jacobs, M.M. Manos, F.X. Bosch, J.A. Kummer, and K.V. Shah Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J Pathol 189 1999 12 19 (Pubitemid 29406813)
12. G.D. Zielinski, P.J. Snijders, and L. Rozendaal The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix J Pathol 201 2003 535 543 (Pubitemid 38256402)
13. X. Castellsague, M. Diaz, and S. de Sanjose Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention J Natl Cancer Inst 98 2006 303 315 (Pubitemid 43338210)
14. H. zur Hausen Papillomaviruses and cancer: from basic studies to clinical application Nat Rev Cancer 2 2002 342 350 (Pubitemid 37328947)
15. P.J. Snijders, R.D. Steenbergen, D.A. Heideman, and C.J. Meijer HPV-mediated cervical carcinogenesis: concepts and clinical implications J Pathol 208 2006 152 164 (Pubitemid 43126109)
16. S.E. Waggoner, S.M. Anderson, S. Van Eyck, J. Fuller, M.C. Luce, and A.L. Herbst Human papillomavirus detection and p53 expression in clear-cell adenocarcinoma of the vagina and cervix Obstet Gynecol 84 1994 404 408 (Pubitemid 24267300)
17. K. Cuschieri, and N. Wentzensen Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia Cancer Epidemiol Biomarkers Prev 17 2008 2536 2545
18. M.E. McLaughlin-Drubin, C.P. Crum, and K. Munger Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogramming Proc Natl Acad Sci USA 108 2011 2130 2135
19. Y.F. Guo, A.J. Liu, X.L. Wang, X.Z. Wu, L. Song, and H.T. Liu Human papillomavirus detection in clear cell carcinoma of the cervix Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 23 2009 82 84
20. J. Stewart III, K. Bevans-Wilkins, C. Ye, and D.F. Kurtycz Clear-cell endocervical adenocarcinoma in a 19-year-old woman Diagn Cytopathol 34 2006 839 842 (Pubitemid 44904286)
21. M.A. Duggan, S.E. McGregor, J.L. Benoit, M. Inoue, J.G. Nation, and G.C. Stuart The human papillomavirus status of invasive cervical adenocarcinoma: a clinicopathological and outcome analysis Hum Pathol 26 1995 319 325
22. K. Milde-Langosch, C. Schreiber, G. Becker, T. Loning, and H.E. Stegner Human papillomavirus detection in cervical adenocarcinoma by polymerase chain reaction Hum Pathol 24 1993 590 594 (Pubitemid 23162225)
23. P. Tenti, S. Romagnoli, E. Silini, N.S. Pellegata, R. Zappatore, and A. Spinillo Analysis and clinical implications of K-ras gene mutations and infection with human papillomavirus types 16 and 18 in primary adenocarcinoma of the uterine cervix Int J Cancer 64 1995 9 13
24. I. Hadzisejdc, M. Krasevic, H. Haller, and B. Grahovac Distribution of human papillomavirus types in different histological subtypes of cervical adenocarcinoma Coll Antropol 31 Suppl 2 2007 97 102
25. S. Nofech-Mozes, M.M. Khalifa, N. Ismiil, V. Dube, R.S. Saad, and P. Sun Detection of HPV-DNA by a PCR-based method in formalin-fixed, paraffin-embedded tissue from rare endocervical carcinoma types Appl Immunohistochem Mol Morphol 18 2010 80 85
26. O. Houghton, J. Jamison, R. Wilson, J. Carson, and W.G. McCluggage p16 Immunoreactivity in unusual types of cervical adenocarcinoma does not reflect human papillomavirus infection Histopathology 57 2010 342 350
27. D.C. Ding, F.W. Chang, and M.H. Yu Huge clear cell carcinoma of the cervix in teenager not associated with diethylstilbestrol: a brief case report Eur J Obstet Gynecol Reprod Biol 117 2004 115 116
28. C.W. Chen, H.M. Hsiao, C.A. Chen, C.Y. Hsieh, and W.F. Cheng Clear cell adenocarcinoma of the uterine cervix Taiwan J Obstet Gynecol 46 2007 453 455
29. J.A. van Dijck, Y. Doorduijn, J.H. Bulten, J. Verloop, L.F. Massuger, and B.A. Kiemeney Vaginal and cervical cancer due to diethylstilbestrol (DES); end epidemic] Vagina- en cervixcarcinoom door diethylstilbestrol (des). Einde epidemie Ned Tijdschr Geneeskd 153 2009 366
30. Federation for proper secondary use of tissue http://www.federa.org/?s= 1&m=82&p=9&v=4#866 2002
31. A.M. de Roda Husman, P.J. Snijders, H.V. Stel, A.J. van den Brule, C.J. Meijer, and J.M. Walboomers Processing of long-stored archival cervical smears for human papillomavirus detection by the polymerase chain reaction Br J Cancer 72 1995 412 417
32. A.T. Hesselink, M.A. van Ham, D.A. Heideman, Z.M. Groothuismink, L. Rozendaal, and J. Berkhof Comparison of GP5+/6+-PCR and SPF10-line blot assays for detection of high-risk human papillomavirus in samples from women with normal cytology results who develop grade 3 cervical intraepithelial neoplasia J Clin Microbiol 46 2008 3215 3221
33. A.J. van den Brule, R. Pol, N. Fransen-Daalmeijer, L.M. Schouls, C.J. Meijer, and P.J. Snijders GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes J Clin Microbiol 40 2002 779 787 (Pubitemid 34208623)
34. B. Kleter, L.J. van Doorn, L. Schrauwen, A. Molijn, S. Sastrowijoto, and J. ter Schegget Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus J Clin Microbiol 37 1999 2508 2517 (Pubitemid 29337270)
35. C.J. Meijer, J. Berkhof, P.E. Castle, A.T. Hesselink, E.L. Franco, and G. Ronco Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older Int J Cancer 124 2009 516 520
36. P.J. Snijders, D.A. Heideman, and C.J. Meijer Methods for HPV detection in exfoliated cell and tissue specimens APMIS 118 2010 520 528
37. V.M. Coupe, J. Berkhof, N.W. Bulkmans, P.J. Snijders, and C.J. Meijer Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening Br J Cancer 98 2008 646 651 (Pubitemid 351214513)